Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 7593787, 9 pages
http://dx.doi.org/10.1155/2016/7593787
Research Article

Expressing Status and Correlation of ARID1A and Histone H2B on Breast Cancer

1Department of Surgery, The Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, China
2Department of Surgery, Zhoupu Hospital of Pudong District, Shanghai, China

Received 16 August 2015; Revised 19 December 2015; Accepted 22 December 2015

Academic Editor: Martin Sebastian Staege

Copyright © 2016 Yan Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. J. Zang, I. Cutcutache, S. L. Poon et al., “Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes,” Nature Genetics, vol. 44, no. 5, pp. 570–574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Jones, M. Li, D. W. Parsons et al., “Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types,” Human Mutation, vol. 33, no. 1, pp. 100–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Huang, Q. Deng, Q. Wang et al., “Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma,” Nature Genetics, vol. 44, no. 10, pp. 1117–1121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Wang, J. Kan, S. T. Yuen et al., “Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer,” Nature Genetics, vol. 43, no. 12, pp. 1219–1223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Gui, G. Guo, Y. Huang et al., “Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder,” Nature Genetics, vol. 43, no. 9, pp. 875–878, 2011. View at Publisher · View at Google Scholar
  6. S. Jones, T.-L. Wang, I.-M. Shih et al., “Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma,” Science, vol. 330, no. 6001, pp. 228–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. N. Wu and C. W. M. Roberts, “ARID1A mutations in cancer: another epigenetic tumor suppressor?” Cancer Discovery, vol. 3, no. 1, pp. 35–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Guan, M. Gao, C.-H. Wu, T.-L. Wang, and I.-M. Shih, “Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions,” Neoplasia, vol. 14, no. 10, pp. 986–993, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Zhang, Q. Sun, M. Shan et al., “Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers,” PLoS ONE, vol. 8, no. 1, Article ID e53931, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Patsialou, D. Wilsker, and E. Moran, “DNA-binding properties of ARID family proteins,” Nucleic Acids Research, vol. 33, no. 1, pp. 66–80, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. N. G. Nagl Jr., A. Patsialou, D. S. Haines, P. B. Dallas, G. R. Beck Jr., and E. Moran, “The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest,” Cancer Research, vol. 65, no. 20, pp. 9236–9244, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. X. S. Li, P. Trojer, T. Matsumura, J. E. Treisman, and N. Tanese, “Mammalian SWI/SNF—a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B,” Molecular and Cellular Biology, vol. 30, no. 7, pp. 1673–1688, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Urasaki, L. Heath, and C. W. Xu, “Coupling of glucose deprivation with impaired histone H2B monoubiquitination in tumors,” PLoS ONE, vol. 7, no. 5, Article ID e36775, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Slowinski, U. Mazurek, G. Bierzynska-Macyszyn et al., “Cell proliferative activity estimated by histone H2B mRNA level correlates with cytogenetic damage induced by radiation in human glioblastoma cell lines,” Journal of Neuro-Oncology, vol. 71, no. 3, pp. 237–243, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Hao, Y. Yu, L. Wang et al., “IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology,” Journal of Proteome Research, vol. 7, no. 9, pp. 3668–3677, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. R. Rhodes, J. Yu, K. Shanker et al., “ONCOMINE: a cancer microarray database and integrated data-mining platform,” Neoplasia, vol. 6, no. 1, pp. 1–6, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. D. R. Rhodes, S. Kalyana-Sundaram, V. Mahavisno et al., “Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles,” Neoplasia, vol. 9, no. 2, pp. 166–180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. D. R. Rhodes, S. Kalyana-Sundaram, V. Mahavisno, T. R. Barrette, D. Ghosh, and A. M. Chinnaiyan, “Mining for regulatory programs in the cancer transcriptome,” Nature Genetics, vol. 37, no. 6, pp. 579–583, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. X.-J. Ma, S. Dahiya, E. Richardson, M. Erlander, and D. C. Sgroi, “Gene expression profiling of the tumor microenvironment during breast cancer progression,” Breast Cancer Research, vol. 11, no. 1, article R7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Radvanyi, D. Singh-Sandhu, S. Gallichan et al., “The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 31, pp. 11005–11010, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Glück, C. Germond, P. Lopez et al., “A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer,” European Journal of Cancer, vol. 34, no. 7, pp. 1008–1014, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Zhao, A. Langerød, Y. Ji et al., “Different gene expression patterns in invasive lobular and ductal carcinomas of the breast,” Molecular Biology of the Cell, vol. 15, no. 6, pp. 2523–2536, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. A. L. Richardson, Z. C. Wang, A. De Nicolo et al., “X chromosomal abnormalities in basal-like human breast cancer,” Cancer Cell, vol. 9, no. 2, pp. 121–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Mamo, L. Cavallone, S. Tuzmen et al., “An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer,” Oncogene, vol. 31, no. 16, pp. 2090–2100, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Zhang, Y. Zhang, Y. Yang et al., “Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance,” Cancer Epidemiology, vol. 36, no. 3, pp. 288–293, 2012. View at Publisher · View at Google Scholar · View at Scopus